<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Puppa G, Senore C, Sheahan K, Vieth M, Lugli A, Zlobec I, Pecori S, Wang L M, Langner C, Mitomi H, Nakamura T, Watanabe M, Ueno H, Chasle J, Conley S A, Herlin P, Lauwers G Y &amp; Risio M (2012) Histopathology Diagnostic reproducibility of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> budding in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>: a multicentre, multinational study using virtual microscopy Aims:  Despite the established prognostic relevance of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> budding in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, the reproducibility of the methods reported for its assessment has not yet been determined, limiting its use and reporting in routine pathology practice </plain></SENT>
<SENT sid="1" pm="."><plain>Methods and results:  A morphometric system within telepathology was devised to evaluate the reproducibility of the various methods published for the assessment of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> budding in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Five methods were selected to evaluate the diagnostic reproducibility among 10 investigators, using <z:chebi fb="1" ids="51686">haematoxylin</z:chebi> and eosin (H&amp;E) and AE1-3 cytokeratin-immunostained, whole-slide digital scans from 50 pT1-pT4 <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The overall interobserver agreement was fair for <z:hpo ids='HP_0000001'>all</z:hpo> methods, and increased to moderate for pT1 <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The intraobserver agreement was also fair for <z:hpo ids='HP_0000001'>all</z:hpo> methods and moderate for pT1 <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Agreement was dependent on the participants' experience with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> budding reporting and performance time </plain></SENT>
<SENT sid="6" pm="."><plain>Cytokeratin immunohistochemistry detected a higher percentage of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> budding-positive cases with <z:hpo ids='HP_0000001'>all</z:hpo> methods compared to H&amp;E-stained slides, but did not influence agreement levels </plain></SENT>
<SENT sid="7" pm="."><plain>Conclusions:  An overall fair level of diagnostic agreement for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> budding in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was demonstrated, which was significantly higher in early <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> and among experienced gastrointestinal pathologists </plain></SENT>
<SENT sid="8" pm="."><plain>Cytokeratin immunostaining facilitated detection of budding <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells, but did not result in improved interobserver agreement </plain></SENT>
</text></document>